Wells PG - Search Results

1

Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency.

de Morais SM, Wells PG. de Morais SM, et al. Among authors: wells pg. Hepatology. 1989 Aug;10(2):163-7. doi: 10.1002/hep.1840100207. Hepatology. 1989. PMID: 2501210

2

In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase.

Hu Z, Wells PG. Hu Z, et al. Among authors: wells pg. J Pharmacol Exp Ther. 1992 Oct;263(1):334-42. J Pharmacol Exp Ther. 1992. PMID: 1403794

3

Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.

de Morais SM, Chow SY, Wells PG. de Morais SM, et al. Among authors: wells pg. Toxicol Appl Pharmacol. 1992 Nov;117(1):81-7. doi: 10.1016/0041-008x(92)90220-m. Toxicol Appl Pharmacol. 1992. PMID: 1440617

4

Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome.

de Morais SM, Uetrecht JP, Wells PG. de Morais SM, et al. Among authors: wells pg. Gastroenterology. 1992 Feb;102(2):577-86. doi: 10.1016/0016-5085(92)90106-9. Gastroenterology. 1992. PMID: 1732127

5

Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.

Kalabis GM, Wells PG. Kalabis GM, et al. Among authors: wells pg. J Pharmacol Exp Ther. 1990 Dec;255(3):1408-19. J Pharmacol Exp Ther. 1990. PMID: 2262910

6

Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.

Wells PG, Zubovits JT, Wong ST, Molinari LM, Ali S. Wells PG, et al. Toxicol Appl Pharmacol. 1989 Feb;97(2):192-202. doi: 10.1016/0041-008x(89)90325-6. Toxicol Appl Pharmacol. 1989. PMID: 2493687

7

In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.

Kubow S, Wells PG. Kubow S, et al. Among authors: wells pg. Mol Pharmacol. 1989 Apr;35(4):504-11. Mol Pharmacol. 1989. PMID: 2539558

8

Cataractogenicity and bioactivation of naphthalene derivatives in lens culture and in vivo.

Lubek BM, Kubow S, Basu PK, Wells PG. Lubek BM, et al. Among authors: wells pg. Lens Eye Toxic Res. 1989;6(1-2):203-9. Lens Eye Toxic Res. 1989. PMID: 2562167

9

Effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on phenytoin-induced embryopathy in mice.

Wells PG, Vo HP. Wells PG, et al. Toxicol Appl Pharmacol. 1989 Mar 1;97(3):398-405. doi: 10.1016/0041-008x(89)90244-5. Toxicol Appl Pharmacol. 1989. PMID: 2609339

10

Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds.

Wells PG, Nagai MK, Greco GS. Wells PG, et al. Toxicol Appl Pharmacol. 1989 Mar 1;97(3):406-14. doi: 10.1016/0041-008x(89)90245-7. Toxicol Appl Pharmacol. 1989. PMID: 2609340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results